Novartis International AG: Novartis Completes Merger With Alcon, Required Total Of 165M Shares Instead Of 215M (ACL)
April 08, 2011 10:04 AM
Novartis (NYSE: ACL) completes merger with Alcon.
* Novartis shares required in transaction total 165 million shares instead of 215 shares million following purchase of Alcon shares in open market
* The 108 million new shares in combination with an additional 57 million shares held in treasury used to fund part of the merger consideration
* Merger of Alcon into Novartis completed following entry in commercial registry
Novartis announced today that it completed the merger of Alcon, Inc. (Alcon; NYSE: ACL) into Novartis. The completion of the merger follows the Novartis shareholders' approval of the merger, as well as the proposed capital increase at the company's Extraordinary Shareholder Meeting today and the subsequent entry of the merger into the commercial registry.
